Detoxification for medication overuse headache is the primary task

被引:52
作者
Olesen, Jes [1 ]
机构
[1] Univ Copenhagen, DK-2600 Glostrup, Copenhagen, Denmark
关键词
Chronic migraine; medication overuse headache; detoxification; topiramate; onabotulinumtoxin A; PLACEBO-CONTROLLED PHASE; CHRONIC MIGRAINE; DOUBLE-BLIND; TRIAL; ONABOTULINUMTOXINA;
D O I
10.1177/0333102411431309
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Common practice in patients overusing medication is to place major emphasis on detoxification. Overview: This is based on decades of disappointing experience trying to treat patients with prophylactics despite medication overuse. Several trials have shown that, when patients are taken off medication overuse, approximately 50% of them get so much better that prophylactic drug treatment is no longer needed. There is no doubt that detoxification by one means or another is of crucial importance in the initial steps of treating patients who have a medication overuse. The methodology for detoxification may vary from country to country. Likewise, it varies whether patients are placed on prophylactic treatment simultaneously with detoxification or after a drug-free period of 2 months. Only future long-term studies can show whether one approach or the other is preferable. Conclusion: Detoxification must always be the first consideration in overusing patients, but obviously accompanied by or followed up by the necessary prophylactic or treatment.
引用
收藏
页码:420 / 422
页数:3
相关论文
共 14 条
[1]  
Aurora SK, 2010, CEPHALALGIA, V30, P793, DOI 10.1177/0333102410364676
[2]   Overuse of acute migraine medications and migraine chronification [J].
Bigal, Marcelo E. ;
Lipton, Richard B. .
CURRENT PAIN AND HEADACHE REPORTS, 2009, 13 (04) :301-307
[3]   OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial [J].
Diener, H. C. ;
Dodick, D. W. ;
Aurora, S. K. ;
Turkel, C. C. ;
DeGryse, R. E. ;
Lipton, R. B. ;
Silberstein, S. D. ;
Brin, M. F. .
CEPHALALGIA, 2010, 30 (07) :804-814
[4]   Reduction in medication-overuse headache after short information. The Akershus study of chronic headache [J].
Grande, R. B. ;
Aaseth, K. ;
Benth, J. S. ;
Lundqvist, C. ;
Russell, M. B. .
EUROPEAN JOURNAL OF NEUROLOGY, 2011, 18 (01) :129-137
[5]   Management of medication overuse headache: 1-year randomized multicentre open-label trial [J].
Hagen, K. ;
Albretsen, C. ;
Vilming, S. T. ;
Salvesen, R. ;
Gronning, M. ;
Helde, G. ;
Gravdahl, G. ;
Zwart, J-A ;
Stovner, L. J. .
CEPHALALGIA, 2009, 29 (02) :221-232
[6]   Predictors of outcome of the treatment programme in a multidisciplinary headache centre [J].
Jensen, Rigmor ;
Zeeberg, Peter ;
Dehlendorff, Christian ;
Olesen, Jes .
CEPHALALGIA, 2010, 30 (10) :1214-1224
[7]   Headache after frequent use of serotonin agonists zolmitriptan and naratriptan [J].
Limmroth, V ;
Kazarawa, Z ;
Fritsche, G ;
Diener, HC .
LANCET, 1999, 353 (9150) :378-378
[8]   Botulinum toxin type A (BOTOX®) for the prophylactic treatment of chronic daily headache:: A randomized, double-blind, placebo-controlled trial [J].
Mathew, NT ;
Frishberg, BM ;
Gawel, M ;
Dimitrova, R ;
Gibson, J ;
Turkel, C .
HEADACHE, 2005, 45 (04) :293-307
[9]  
Olesen J., 2006, The Headaches, V3rd
[10]   Licence for Botox in so-called chronic migraine [J].
Olesen, Jes ;
Tfelt-Hansen, Peer .
LANCET, 2010, 376 (9755) :1825-1826